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ABSTRACT
pVHL is a tumor suppressor. The lack of its function leads to various tumors, 
among which ccRCC (clear cell renal cell carcinoma) has the most serious outcome 
due to its resistance to chemotherapies and radiotherapies. Although HIF promotes 
the progression of ccRCC, the precise mechanism by which the loss of VHL leads 
to tumor initiation remains unclear. We exploited two zebrafish vhl mutants, vhl 
and vll, and Tg (phd3:: EGFP)i144 fish to identify crucial functions of Vhl in tumor 
initiation. Through the mutant analysis, we found that the role of pVHL in DNA repair 
is conserved in zebrafish Vll. Interestingly, we also discovered that Hif activation 
strongly suppressed genotoxic stress induced DNA repair defects and apoptosis in 
vll and brca2 mutants and in embryos lacking ATM activity. These results suggest the 
potential of HIF as a clinical modulator that can protect cells from accumulating DNA 
damage and apoptosis which can lead to cancers and neurodegenerative disorders.
INTRODUCTION
In humans, mutations in the pVHL protein, 
a tumor suppressor protein, predispose patients 
to Von Hippel Lindau (VHL) disease, a rare form 
of dominantly inherited cancer syndrome. The 
patients suffer from recurrent cysts and tumors 
that can develop into malignant tumors in multiple 
tissues and organs throughout their lifetime. These 
include hemangioblastomas of retina and the central 
nervous system, cysts in pancreas and kidneys, 
pheochromocytoma and clear cell renal cell carcinoma 
(ccRCC). Among these, ccRCC is an important cause of 
death in the VHL patients. It is difficult to be diagnosed 
at early stages when the tumors are localized and can 
be treated by surgery, and the advanced forms of tumor 
are extremely resistant to chemotherapies and radiation 
therapies. pVHL is also mutated in a majority of cases 
of the sporadic form of ccRCC, indicating that VHL is a 
major tumor driver in ccRCC [1, 2].
pVHL is best known as a negative regulator of 
Hypoxia Inducible Factor (HIF) transcription factors 
that play crucial roles for the adaptation of cells to the 
hypoxic environment. HIF transcription factors consist 
RIWZRVXEXQLWVR[\JHQVHQVLWLYHĮDQGFRQVWLWXWLYHO\
SUHVHQW ȕ ,Q D QRUPDOR[\JHQ WHQVLRQ HQYLURQPHQW
+,)Į LV K\GUR[\ODWHG E\ R[\JHQ VHQVLQJ HQ]\PHV
Prolyl Hydroxylases (PHDs) that use oxygen as 
VXEVWUDWHV2QFHLWLVK\GUR[\ODWHG+,)ĮLVGHJUDGHG
by E3 ubiquitin ligase complex where pVHL is a 
substrate recognition subunit. However, when cells 
are exposed to hypoxia, the inactivation of PHD 
HQ]\PHV OHDG WR+,)ĮVWDELOL]DWLRQ LWV WUDQVORFDWLRQ
into the nuclei and the formation of functional 
KHWHURGLPHUVZLWK+,)ȕ VXEXQLW+,)KHWHURGLPHUV
bind to the HIF responsive element (HRE) in their 
target genes to activate genes that are involved in the 
adaptation process in hypoxia such as angiogenesis, 
erythropoiesis, glucose uptake, glycolysis, cell 
proliferation and cell survival [3, 4].
           Research Paper
Oncotarget1110www.oncotarget.com
In the absence of VHL, regardless of the 
environmental oxygen tension, HIF signaling is constantly 
activated mimicking hypoxic conditions. Tumors are often 
hypoxic at their core and the activated HIF is known to 
be advantageous for the survival of tumor cells and to 
be associated with poor prognosis in various cancers 
including ccRCC [5]. Understanding the molecular 
pathways of ccRCC led to the development of a few target 
therapies. Therapies that target angiogenesis have been a 
logical approach to treat ccRCC, but only have temporary 
effect that are accompanied by significant side effects. 
Alternative approaches may be developed through deeper 
understanding of the role of VHL.
There are a multitude of HIF independent 
functions of pVHL that could be potentially targeted for 
ccRCC treatment, although these are not as intensively 
investigated as HIF regulation. These include microtubule 
stabilization and maintenance of the primary cilium, 
regulation of the extracellular matrix formation, and 
control of cell senescence and apoptosis, transcriptional 
regulation [6] and DNA repair [7, 8]. The mutations in 
pVHL that cause pheochromocytoma retain the ability to 
regulate HIF degradation, indicating that HIF independent 
roles of pVHL are important for tumorigenesis [9]. Also, 
DFWLYDWLQJPXWDWLRQV LQHLWKHU+,)ĮRU+,)Į WKDWDUH
associated with ccRCC development, have not been 
identified in ccRCC patients [10]. In contrast to earlier 
studies with ccRCC cell lines and tumor xenograft studies 
ZKLFKVXJJHVWHGWKHUROHRI+,)ĮDVDWXPRUVXSSUHVVRU
more recent mouse transgenic model with constitutive 
DFWLYDWLRQ RI +,)Į GHPRQVWUDWHG WKH UROH RI +,)Į
in the early ccRCC lesion formation, such as renal cyst 
and clear cell morphology. Nevertheless, the transgenic 
animal did not reproduce ccRCC faithfully with invasion 
and metastasis [1113] indicating that HIF independent 
roles of pVHL could also be important for the ccRCC 
development [14, 15].
Besides accumulated HIF, genomic instability is one 
of characteristics of ccRCC. Evidence suggests that the 
accumulation of DNA lesions in our body is associated 
with cancer development and aging [16]. Indeed, inherited 
mutations in the genes that play important roles in the DNA 
repair pathways predispose patients to cancer development 
or premature aging [17]. For example, mutations in one 
allele of the BRCA2 gene that promotes double strand 
break repair (DSB) by homologous recombination (HR), 
increase susceptibility to breast and ovarian cancer, 
and mutations in ATM that is crucial for DNA repair 
and cell cycle control upon DNA damage, cause Ataxia 
-Telangiectasia (A-T) syndrome that is characterized by 
the very high risk of malignancy, radiosensitivity and 
progressive ataxia. Heterozygous individuals have an 
increased risk of cancer [18, 19]. In line with this, Metcalf 
et al. demonstrated that pVHL is required for DSB repair 
in ccRCC cell lines, implicating the role of pVHL in 
DNA damage repair as a cause of the genomic instability 
in ccRCC [7]. In this study, pVHL was hypothesized to 
work together with ATM upon DNA damage to trigger 
downstream signaling for the recruitment of DNA repair 
proteins at the site of DNA damage.
Similarly, Scanlon et al. demonstrated that there was 
an accumulation of DNA damage in VHL defective ccRCC 
cell lines compared to VHL complemented cells [8]. There 
was also downregulation of genes that regulate DSB repair 
and mismatch repair (MMR) in the ccRCC cells, that may 
explain the increase in the DNA damage seen. The authors 
suggest that the VHL deficient cells activate processes 
that are similar to those in the cells exposed to hypoxia. 
It was speculated that the downregulation of DNA repair 
genes in ccRCC cell lines is due to the activation of HIF2 
rather than HIF1, since ccRCC cells expressing only 
HIF2 exhibit the same gene expression profile as that 
of the cells expressing both HIF transcription factors, 
i. e. downregulated DNA repair genes. This study also 
demonstrated the increased sensitivity of ccRCC cells to 
PARP inhibitor likely because of the DSBR defect in the 
ccRCC cells.
Therefore, it is clear that the role of VHL in the 
DNA repair is associated with ccRCC development. 
However, there are fundamental discrepancies in the 
above two studies. Although both studies were performed 
using ccRCC cell lines, Metcalfe et al. reported that 
the role of VHL in DSBR is HIF independent, whereas 
Scanlon et al. suggested that the defects in the DNA 
repair in the vhl mutant cells are similar to those in the 
cells exposed to hypoxia and they are likely to involve 
HIF2 transcription factor. This is the limitation of 
the studies using isolated cells: the cells accumulate 
mutations in the adaptation process and become different 
from the tumours they are originated from, although 
cell lines have certainly been extremely valuable in 
identifying cancer drugs (e. g., PARP inhibitors) [20]. 
In addition, the drug responses in the cell lines often 
cannot be recapitulated in human clinical trials [21, 22]. 
Therefore, to consolidate the findings in the cell lines we 
need a whole organism model in which cells maintain 
their contextual environment and do not undergo the 
adaptation process in the laboratory environment. 
Besides, already transformed cancer cell lines are difficult 
to use for studying the cancer initiation.
More importantly, ccRCC is notorious for its 
resistance to chemotherapeutic reagents; therefore, it can 
be speculated that if there is a defect in the DNA repair 
in the ccRCC as the above two papers suggest, the tumor 
cells will be extremely sensitive to, rather than resistant to, 
the DNA damaging reagents further emphasizing the limits 
of cell lines for studies. We hypothesize that even if the 
DNA repair function of VHL is important for the initiation 
of ccRCC development, there must be mechanisms that 
compromise the effect of the loss of its function and 
provide resistance to therapies as ccRCC progresses. 
,QGHHGWKHDFWLYDWLRQRI+,)ĮLVNQRZQWREHDVVRFLDWHG
Oncotarget1111www.oncotarget.com
with the resistance of various tumors to chemo and radio 
therapies by mechanisms that are extremely diverse 
and complex, e.g.>@6LPLODUO\+,)ĮZDVVKRZQWR
provide the radioresistance in hypoxic mice mesenchymal 
stromal cells by upregulating DNA repair proteins [24]. 
pVHL is also known to regulate p53 that is another crucial 
transcription factor in the adaptation of cells in response 
to genotoxic stress and its malfunction provides various 
tumours with resistance to chemo and radio therapies 
[25]. Therefore, using zebrafish as a whole organismal 
model, we aim to understand the role of HIF dependent 
and independent role of VHL in DNA repair and apoptosis 
and the role of VHL/HIF in the p53 regulation in response 
to genotoxic stress.
Zebrafish provides an excellent high throughput 
vertebrate model system. Nearly 70% of human genes 
have orthologous genes in zebrafish and when only 
disease related genes are considered, around 82% 
of genes are associated with at least one zebrafish 
orthologue [26]. Zebrafish also provides advantages 
over higher vertebrate models such as fecundity, in 
vitro fertilisation and easy genetic manipulation. Due 
to a genome duplication event, there are two zebrafish 
VHL orthologues, vhl and vll (vhl like). Previously we 
reported the role of vhl in the HIF regulation and the null 
zebrafish vhl mutant mimics Chuvash polycythemia in 
human [2729]. In this report, we generated a mutant for 
the vhl paralogous gene, vll, by zinc finger endonuclease 
and investigated the function of vhl and vll in the DNA 
repair. We took advantage of Tg(phd3:: EGFP)i144 
reporter line which expresses a high level of EGFP in the 
absence of functional vhl but a minimal level of EGFP 
in the presence of one wild type allele of vhl [30]. We 
used vhl+/; Tg(phd3:: EGFP)i144 fish as a unique tool to 
study in vivo genomic instability using the vhl gene as a 
sentinel, since cells express a high level of EGFP when 
the remaining wild type vhl is lost.
Interestingly the function of human VHL in HIF 
regulation and DNA repair seems to be partially segregated 
into zebrafish Vhl and Vll respectively, Hif regulation in 
Vhl and DNA repair in Vll. We found that the role of Vll in 
the DNA repair is Hif independent. Surprisingly however, 
we identified a role of Hif in the promotion of DNA 
repair and protection of embryos from apoptosis when 
embryos were exposed to genotoxic stress. Upregulated 
Hif suppresses not only the DNA repair defects in the vll 
mutants but also the defects in the brca2 mutants and the 
embryos in which ATM function is inhibited. We hope 
our results will provide a better understanding of ccRCC 
development and open up great possibilities for the HIF 
activators to be exploited for the treatment of disorders 
associated with DNA repair defects. We think our vhl; 
vll double mutants can also provide an especially useful 
system for drug discovery to identify drugs that could 
overcome the resistance of tumour cells to chemo- and 
radio therapies.
RESULTS
Genetic knock out of vhl paralogue vll, by target 
specific endonuclease
There are two zebrafish vhl orthologues, vhl and 
vll (vhl like). The function of zebrafish vhl has been well 
characterized and documented [27, 28]. The function 
of its paralogue vll, however, has not been reported yet. 
Therefore, to fully appreciate the function of Vhl in 
zebrafish, we created a genetic knock-out of vll by a zinc 
finger nuclease. The mutant allele lacks 23 nucleotides 
around transcription starting site including ATG and it is 
expected to be functionally null (Figure 1A). Sequence 
analysis revealed that zebrafish Vhl shares 70% of 
similarity with human VHL whereas zebrafish Vll shares 
52% of similarity (Figure 1B). As we previously reported, 
vhl mutant embryos can survive up to 9dpf, and the mutant 
embryos show typical hypoxic responses such as increased 
blood vessel formation, upregulated erythropoiesis and 
hyperventilation [27]. On the contrary, vll mutant embryos 
are fertile and fully viable, and show no morphological 
signs of Hif upregulation (Figure 1C).
When we examined the expression of key Hif target 
genes by qPCR in the vll/ mutant embryos, in spite of 
the lack of visible phenotypes, there was a modest level 
of upregulated Hif target genes in the vll/ mutants. 
Furthermore, there was a remarkable and more than 
additive upregulation of HIF target genes in the vhl/; 
vll/ double mutants (Table 1). The characteristics of vhl 
mutants by Hif upregulation, such as the reduced usage of 
yolk and slowdown in growth, were also more enhanced 
in vhl/; vll/ double mutants in comparison to vhl/ 
single mutants (Figure 1C). We concluded that, although 
vll is not required for Hif regulation in the presence of vhl, 
it plays an important role in Hif regulation in the absence 
of vhl, sharing a functional redundancy with vhl.
Previously we found that one of the Hif 
hydroxylases, phd3, is a direct target of Hif, with HREs 
identified in its promoter [31, 32], and its expression 
most dramatically reflects the activity of Hif signaling. 
Accordingly, we used a BAC engineered phd3 reporter 
line that expresses EGFP under the phd3 promoter 
as a tool to measure the level of HIF activation [30]. 
As expected, the phd3 transgenic vhl homozygous 
mutant embryos expressed a very high level of EGFP 
reflecting Hif activation. The expression of EGFP in 
vll/; Tg (phd3:: EGFP)i144 mutant embryos, however, 
was indistinguishable from that of wild type. This is 
not in agreement with the modest upregulation of phd3 
expression in vll/ embryos in our qPCR data. When 
we repeated qPCR with rps29 as a reference gene instead 
of previous ȕDFWLQ, the modest upregulation of phd3 
expression was no longer observed in vll/; Tg (phd3:: 
EGFP)i144 mutant embryos (Supplementary Table 1). 
When we examined the vhl/; vll/; Tg (phd3:: EGFP)
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i144 double mutants, there was an augmented expression of 
EGFP transgene in comparison to vhl/ single mutants 
(Figure 1C and Supplementary Table 1), which confirms 
the redundant role of vll and vhl in Hif regulation.
Zebrafish vll/ mutant fish are more susceptible 
to loss of heterozygosity (LOH) in the vhl locus
Interestingly, in heterozygous vhl+/ mutants, the 
expression of Tg (phd3:: EGFP)i144 is very low whereas vhl
/ homozygous mutants express a very high level of EGFP, 
indicating that one copy of Vhl is sufficient to suppress 
the expression of Hif in the vhl+/ heterozygous mutants. 
While we were examining the vhl+/; vll/ mutant adult 
fish, we came across very bright EGFP expressing cells in 
the mutant fish that were not observed in vhl+/; vll+/+ fish. 
This meant that there was an increased rate of spontaneous 
LOH of vhl locus in the vll/ mutants in comparison to that 
in wild type fish (Figure 2A and 2B; quantified in 2C).
We also examined vll/ embryos to see whether 
there is an increase in the spontaneous LOH at the vhl 
locus. Unlike in adults, however, LOH events in the vhl 
locus were much rarer in the early embryos. Nevertheless, 
we found a statistically significant increase in the 
percentage of vll/ embryos that showed at least one 
LOH event from 7% (n = 220) to 19% (n = 215), when we 
compared a large number of vhl+/; Tg (phd3:: EGFP)
i144 and vhl+/vll/; Tg (phd3:: EGFP)i144 embryos. The 
number of LOH cells per positive embryo was also higher 
in vll/ embryos (Figure 2E and 2F).
From this observation, we realized that vhl+/ 
heterozygous Tg (phd3:: EGFP)i144 transgenic fish could 
be an excellent tool to study genomic instability. When 
the cells experience any genotoxic stress which introduces 
strand breaks or other damage in the DNA of the vhl locus, 
the cells that repair the damage perfectly, e. g. by HR, will 
remain EGFP negative. On the other hand, if, for instance, 
a DNA break is repaired by mechanisms that introduce 
errors or if there are defects in the DNA repair pathways, 
the cells will lose the remaining wild type allele of vhl 
and will express a very high level of EGFP (Figure 2D). 
Therefore, we reasoned that vll might be required for 
maintaining genomic stability and the role of human VHL 
in DNA repair might be conserved in zebrafish vll.
Zebrafish vll/ mutant embryos increase LOH 
at vhl locus in response to ionizing irradiation
Using Tg (phd3:: EGFP)i144 as a tool to study the 
genomic instability, we treated vll/ mutant embryos with 
a high level of X-ray to introduce DSBs. We hypothesized 
that if vll, like the human VHL gene, is required for the 
DNA DSB repair by HR upon DNA damage the repair of 
irradiation induced DNA damage in the vhl locus in vll/ 
mutants would not be as efficient as in wild type embryos, 
and there will be an increase in the number of EGFP 
positive vhl/ cells in the vll/ mutant. We irradiated 
vhl+/; vll/ ;Tg (phd3:: EGFP)i144 transgenic embryos 
with X-rays at 1dpf and examined the LOH at vhl locus at 
5dpf. Its LOH rate was compared with that of irradiated 
vhl+/; vll+/+ embryos. We found that the LOH rate 
in the vhl locus in the vll/ mutant embryos was much 
higher than that in vll+/+ wild type embryos indicating the 
role of vll in accurate DNA repair (Figure 3A).
Figure 1: A vll mutant allele, vll216, is generated by a zinc finger nuclease. (A) The mutant allele harbors 23 nucleotide deletion 
around translational starting site. (B) Zebrafish Vll shares 52% homology with human VHL. The seven amino acids that are lost in vll216 
are highlighted in red. Even if the next available ATG (highlighted in blue) were to be used as an alternative translational start site, it 
would lead to a protein that lacks most of the predicted Hif binding domain. (C) Since phd3 (egln3) expression most dramatically reflects 
the increased Hif expression, we used Tg (phd3:: EGFP)i144 transgenic line as a Hif signaling readout. Zebrafish vll/ embryos do not 
show any morphological phenotype and the Tg (phd3:: EGFP)i144 expression in the mutants was identical to that in the wild type embryos. 
Reflecting the role of Vll in Hif regulation in the absence of Vhl, there was an enhanced GFP expression in the vhl/; vll/ double mutant 
embryos in comparison to that in vhl/ embryos. Scale bar: 1 mm.
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Next, we used the CRISPR/Cas9 system that 
specifically targets the vhl locus, to introduce a targeted 
DNA DSB in vhl. Using EGFP expression in the Tg 
(phd3:: EGFP)i144 as a readout for LOH, we injected a 
single gRNA against vhl into 1-cell stage vhl+/; vll/ 
embryos and examined the LOH at 5dpf with the equally 
injected Tg (phd3:: EGFP)i144; vhl+/; vll+/+ embryos as 
their control. Similar to the results from X-ray treatment, 
there was an increased number of EGFP positive cells 
in the vll/ mutants in comparison to vll+/+ wild type 
embryos, indicating that accurate DNA repair is defective 
in the vll mutant (Figure 3B).
Loss of heterozygosity can be due to various 
mechanisms either local mutations or more significant 
changes like loss of an entire chromosomal region. We 
investigated efficiency of mutagenesis with CRISPR/Cas9 
system that targets not only vhl but also another gene, 
Androgen Receptor (AR). We injected guide RNAs targeting 
AR /vhl into vll/ mutants and wild type embryos to quantify 
mutagenesis rates in the vll/ mutants in comparison to 
wild type embryos. After the injection, genomic DNAs were 
extracted and PCR was performed to amplify the sequences 
around the target sites. We carried out deep sequencing of 
the PCR products from injected samples. This revealed that 
there was no significant increase in the mutation frequencies, 
or in the size of indels in the vll/ mutants in both AR and 
vhl targeting CRISPR injected embryos (Supplementary 
Figure 1). This suggests that increased LOH in the vll/ 
embryos might be due the loss of larger regions of the 
chromosome or complex rearrangements of chromosomes 
that cannot be detected by PCR methods [33].
To exclude the possibility that vll protects embryos 
from the DNA damage induction rather than it being 
involved in DNA repair, we examined the expression 
RI Ȗ+$; ZKLFK LV RQH RI WKH HDUOLHVW UHVSRQVHV WR
DNA damage after the irradiation. We irradiated vhl+/ 
and vhl+/; vll/ embryos at 1dpf and fixed them 
immediately after the X-ray treatment. The fixed embryos 
ZHUH H[DPLQHG IRU WKHLU Ȗ+$; IRFL IRUPDWLRQ 7KLV
revealed that embryos of all genotypes showed equally 
GLVWULEXWHG IRUPDWLRQ RI Ȗ+$; IRFL DIWHU WKH ;UD\
treatment suggesting that DNA damage was equally 
introduced in all genotypes (Supplementary Figure 2).
vhl/; vll/ double mutants are protected from 
X-ray induced apoptosis
We wondered whether vhl and vll have functional 
redundancy in their DNA damage repair role, and wanted 
to investigate the possibility that vhl might play a major 
role in the DNA repair, in the same way as in their Hif 
regulation. Unfortunately, however, we cannot use our 
Tg(phd3:: EGFP)i144 line as a tool to study the role of 
vhl in genomic instability because all the cells in the vhl 
mutants already lack both alleles of wild type vhl and 
express a very high level of EGFP. Therefore, we decided 
to examine the sensitivity of vhl/; vll/ double mutants 
to genotoxic stress compared with that of vll/ mutant. 
We reasoned that if vhl and vll are both required for 
the DNA repair, the double mutant would be extremely 
sensitive to the genotoxic stress.
We pair mated vhl+/; vll/; Tg (phd3:: EGFP)
i144 fish to expose vhl/; vll/ double mutants to X-ray 
treatment. When the collected embryos were irradiated at 
1dpf and examined at 5dpf, we found that around a quarter 
of embryos were extremely well protected from the X-ray 
induced cell death. We separated these protected embryos 
from the rest and examined them under the fluorescent 
microscope. Surprisingly, it turned out that all the 
protected embryos were vhl/; vll/ double mutants with 
a very high level of EGFP expression (Figure 4A4D). 
This was in strong contrast to our speculation that double 
mutant would be extremely sensitive to the genotoxic 
stress. TUNEL staining confirmed a much reduced number 
of apoptotic cells in the double mutants in comparison to 
their siblings (Figure 4E4G).
Hif activation protects embryos from genotoxic 
stress induced apoptosis
We then wanted to identify what makes vhl/; vll
/ double mutants resistant to the X-ray treatment. The 
Table 1: The qPCR results reveal the modest role of Vll and the synergistic effect of the loss of Vhl 
and Vll in the Hif regulation
Gene Name Gene Symbol vll vs wt vhl vs wt vhl; vll vs wt
egl-9 family hypoxia-inducible factor 3 egln3 3.51 30.20 281.99
vascular endothelial growth factor Aa vegfaa 4.11 4.89 26.98
aminolevulinate, delta-, synthase 2 alas2 1.82 11.60 15.41
MAP kinase interacting serine/threonine kinase 2b mknk2b 3.53 6.56 14.24
GATA binding protein1a gata1a 1.99 2.79 3.63
We performed qPCR to examine the expression level of a few Hif target genes. There was a modest upregulation of Hif target 
genes in vll mutants indicating the minor role of vll in Hif regulation in the presence of vhl. However, a striking upregulation 
of Hif target genes was observed in vhl/; vll/ mutants suggesting the redundant role of vhl and vll in the Hif regulation. 
The values are fold changes, and they are means of three technical and two biological replicates.
Oncotarget1114www.oncotarget.com
most obvious effect of the double mutation is upregulation 
of Hif signaling. Therefore, we sought to upregulate Hif 
signaling independently of Vhl and Vll to test whether 
Hif upregulation could protect embryos from cell death 
induced by genotoxic stress. We employed a cancer 
therapeutic reagent Camptothecin (CPT), which induces 
DSBs in replicating cells [3436]. Embryos from vhl+/; 
vll/ pair mating were treated with 20 nM CPT at 32hpf 
overnight. The CPT treated embryos were examined for 
their sensitivity to CPT at 5dpf. All the embryos treated 
Figure 2: The adult vll/ mutant fish are more susceptible to LOH in the vhl locus. (A and B) When we examined 6 
months old vll/ mutant fish, there was an increased number of spontaneous LOH in the vhl locus in vll/ mutant fish in comparison to 
vll+/+ wild type fish. The increased LOH in vll/ mutant fish was quantified in (C) ****p < 0.0001, unpaired t-test. Scale bar: 1 mm (D) 
Schematic diagram illustrating the principle of our reporter system that if DNA damage is introduced into the remaining wildtype vhl allele, 
for instance by a CRISPR, in the vhl+/: Tg (phd3:: EGFP)i144 fish in response to the genotoxic stress and the damage is well repaired 
and no frameshift is introduced, the cells will remain EGFP negative. However, if the DNA damage introduced into the wild type allele is 
not repaired properly, the cells will lose heterozygosity and express very bright EGFP expression. (E) we also examined the spontaneous 
LOH at the vhl locus in vll/ mutant embryos. Although the number of LOH events was much lower than that in adults and a majority of 
embryos did not have any LOH events, we found a statistically significant increase in the number of embryos that experienced a LOH event 
in vll/ embryos in comparison to wild type embryos. ****p < 0.0001, Chi-square (and Fishers exact) test. (F) There was an increase in the 
number of EGFP positive cells in vll/ embryos in comparison to wild type embryos. ***p < 0.001, unpaired t-test.
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with CPT, except vhl/; vll/ double mutants that 
express a high level of EGFP, died by 5dpf with severe 
cell death (Figure 5A and 5B) confirming our previous 
observation. Further, when a parallel batch of embryos 
were treated with Hif activator (JNJ-42041935, 100 
uM) for 8 hours prior to CPT treatment, all the embryos, 
regardless of their vhl genotype, were protected from CPT 
treatment induced death, suggesting that the protection 
of vhl/; vll/ double mutants from CPT treatment 
was indeed due to elevated HIF activation (Figure 5C 
and 5D). To confirm these data further, we treated wild 
type embryos with CPT at 20 nM, with or without pre-
treatment with Hif activator. This revealed that all the 
wild type embryos treated with CPT alone died by 5dpf 
(Figure 5E), whereas the majority of embryos survived 
when they were treated with HIF activator prior to CPT 
treatment (Figure 5F and Supplementary Figure 3). Hif 
activator proved to be very effective at a wide range of 
concentrations: the protective effect has been seen at the 
concentration as low as 25 uM and as high as 200 uM 
without any sign of toxicity. Chemical Hif activators 
function by inhibiting cellular hydroxylases and could 
therefore have additional effects. To further show that 
the protection of the embryos is due to upregulated Hif, 
ZH LQMHFWHG FRQVWLWXWLYHO\ DFWLYH IRUPV RI +LIĮ DQG
+LIĮWRLQGXFHDKLJKOHYHORI+LIDFWLYDWLRQLQVWHDGRI
chemically activating Hif. This also showed that all the 
Hif injected embryos were protected from CPT induced 
apoptosis, confirming the specificity of chemical Hif 
activator (Figure 5G, compare to 5E). When we examined 
apoptosis in the Hif activator treated embryos by TUNEL 
staining after CPT treatment at 10 nM concentration, there 
was a significant reduction in the TUNEL positive cells 
in the Hif activator treated embryos in comparison to the 
untreated wild type embryos (Supplementary Figure 3).
p53 expression is decreased in the vhl/; 
vll/ double mutants and in vhl/ mutants in 
comparison to their siblings
Previously, a direct role of VHL in p53 stabilisation 
and transactivation has been reported, with diminished 
p53 protein levels and activity in the absence of vhl 
[37]. Since we observed reduced apoptosis in the vhl/; 
vll/ mutants and Hif activated embryos in response to 
genotoxic stress, we questioned whether the reduction in 
apoptosis in these embryos is due to the downregulation 
in p53 expression. According to the previous studies 
Figure 3: There is an increase in LOH in vll/ embryos in response to X-ray treatments and CRISPR injection. (A) 
There was an increased LOH in the vhl locus in vll/ embryos in response to X-ray treatments. ****p < 0.0001, unpaired t-test. (B) Injection 
of gRNA/Cas9 against vhl locus induced increased LOH at the vhl locus in vll/ embryos in comparison to vll+/+ wild type embryos. B 
is a composite image of 14 individual tail images, white lines separate different genotypes. ***p < 0.001, one way ANOVA; Holm-Sidaks 
multiple comparison test. Scale bars: 0.5 mm.
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in zebrafish and cell culture systems, full length p53 is 
induced immediately in response to X-ray treatment to 
remove the cells with excessive DNA damage beyond 
repair and ensure the cells do not progress through the 
FHOOF\FOHDQGSUROLIHUDWH$VKRUWIRUPǻSWKDWLV
a direct target of full length p53 and transcribed from the 
C-terminus of intron 4 of full length p53, is induced much 
later than the full length p53 to promote DNA DSB repair 
and to antagonise the pro-apoptotic activity of full length 
p53 [38].
Considering the suppressed apoptosis phenotype 
observed, we speculated that full length of p53 would 
be downregulated in the vhl/; vll/ double mutants. 
:HȖUD\HGHPEU\RVIURPvhl+/; vll/ pair mating and 
performed q-PCR against full length p53 and the short 
form of p53. There was a dramatic reduction in both 
isoforms of p53 expression in the vhl/; vll/ mutant 
embryos in comparison to their siblings (Figure 6A and 
6B). p53 suppression in the vhl/; vll/ mutants is likely 
to occur due to the role of Hif in p53 regulation rather than 
the direct role of Vhl in p53 regulation as Roe et al. [37] 
suggests, since Hif activator treated embryos also have 
reduced apoptosis.
To further confirm that the protection of embryos 
from DNA damage induced apoptosis in the Hif activated 
embryos may be due to downregulation in p53, we 
treated embryos from vhl+/; vll/ incross with 10 nM 
CPT at 32hpf overnight and the induced levels of p53 
DQGǻSSURWHLQZHUHH[DPLQHGE\:HVWHUQ%ORWLQ
vhl/; vll/ embryos and in their siblings. This revealed 
Figure 4: vhl/; vll/ double mutants are protected from X-ray induced apoptosis. (AD) The embryos from vhl+/; 
vll/ pair mating were collected and the embryos were exposed to X-ray treatment at 1dpf. Then the treated embryos were examined at 
5dpf. There were clear differences in response to X-ray treatment; majority of embryos were severely affected by X-ray treatment whereas 
around 25% of the embryos were well protected without much sign of cell death. We classified these embryos and looked at them under 
the fluorescent microscope. This revealed that all the protected embryos were EGFP positive vhl/; vll/ double mutants. (E and F) The 
embryos were collected from the vhl+/; vll/ pair mating, and then exposed to X-ray at 1dpf. The embryos were fixed 3 hours post X-ray 
and we analysed the cell death in the head region with TUNEL. This showed extremely decreased TUNEL positive cells in the vhl/; 
vll/ double mutants in comparison to their siblings. (G) Quantification of TUNEL stain. n = 3, **p < 0.01, unpaired t-test. Scale bars: 1 
mm (AD) and 0.2 mm (E&F).
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that the induction of both isoforms of p53 was clearly 
attenuated in vhl/; vll/ embryos, which is consistent 
with our qPCR data (Figure 6C).
To investigate if a reduced p53 level in the vhl/; 
vll/ double mutants may suffice to suppress apoptosis 
in the mutants, we investigated the effect of p53 
downregulation on the apoptosis, using p53 morpholino 
injection. When we injected an efficient p53 morpholino 
(Supplementary Figure 4) into the embryos that were 
collected from vhl+/; vll/ pair mating and treated them 
with 10 nM CPT, we observed all the injected embryos 
were protected from CPT induced apoptosis regardless 
of their genotype (Figure 7B), to a similar level as in 
Hif activator treated embryos (Figure 7C), in contrast to 
uninjected controls (Figure 7A) in which only the vhl/; 
vll/ double mutants are protected from CPT treatment; 
quantified in Figure 7D. These data are consistent with the 
idea that double mutants can be protected from genotoxic 
stress due to a low level of p53 expression. We wondered 
whether Hif activation leads to suppression of apoptosis 
by additional mechanisms other than downregulating 
p53. We found that there was a further reduction in 
the CPT induced apoptosis in p53 morphant when the 
morphant was pre-treated with Hif activator before the 
CPT treatment. This suggests Hif plays a protective role 
not only through the downregulation of p53 but also 
independent of p53. Similarly, p53 knock down enhanced 
the Hif activation provided protection in response to CPT 
treatment, suggesting that Hif suppresses the p53 induction 
but does not fully eliminate its function (Supplementary 
Figure 5).
Hif activation protects embryos from genotoxic 
stress induced DNA damage
The results clearly demonstrate the role of Hif 
in the suppression of apoptosis, probably through 
downregulation of p53. There are two scenarios that can 
explain these observations, either lack of p53 activation 
prevent cells with severe DNA damage from undergoing 
apoptosis, and consequently these cells with accumulated 
DNA damage will contribute to the cell population 
of later embryos, or alternatively HIF might have a 
truly genoprotective role, improving the resilience of 
the genome to DNA damage, thereby reducing the p53 
activation. To test whether Hif activation plays a role in 
the genoprotection, we decided to test its effect on the 
increased DNA damage in the vll mutants. We treated 
vll/ mutants with HIF activator for at least 2 hours 
prior to X-ray treatment at 24hpf. These embryos were 
heterozygous for vhl and carried Tg (phd3:: EGFP)i144 to 
allow the detection of LOH levels for vhl, as described 
Figure 5: Hif activation protects embryos from CPT induced apoptosis. (A and B) The embryos from vhl+/; vll/ pair 
mating were treated with 20 nM CPT. The majority of embryos did not survive until 5dpf except a few embryos. All the embryos that 
survived were EGFP positive vhl/; vll/ double mutants. (C and D) When the embryos were treated with Hif activator for 8 hours prior 
to the CPT treatment, all the embryos became EGFP positive and survived until 5dpf. (E) When wild type embryos were treated with CPT, 
the embryos did not survive at 5dpf. (F) However, most of embryos that are treated with Hif activator prior to CPT treatment survived at 
5dpf. (G7KHHPEU\RVLQMHFWHGFRQVWLWXWLYHO\DFWLYH+LIĮDOVRVXUYLYHGDWGSI6FDOHEDUVPP
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previously. We would expect that if cells with damaged 
DNA fail to undergo apoptosis due to lack of p53 function, 
more cells with LOH might be visible per embryo, but if 
Hif has a role in protecting cells from DNA damage, the 
LOH rate will be reduced. The embryos were examined 
for their LOH at 5dpf. This revealed that vll/ mutant 
fish treated with Hif activator had significantly decreased 
LOH (Figure 8B and 8D; quantified in 8E), suggesting 
that Hif itself has a role in the protection of embryos from 
DNA damage and that the role of Vll itself in DNA repair 
is likely to be Hif independent. In addition, Hif activator 
treated embryos looked a lot healthier than untreated 
embryos, which is consistent with the results from CPT 
treatment. To quantify the latter we used embryonic eye 
size as an easily measurable surrogate for overall health, 
and found it to be significantly increased (compare Figure 
8A and 8C; quantified in 8F).
Then we asked whether downregulation of p53 has 
any effect on the DNA repair function of Hif. We injected 
p53 morpholino into the embryos collected from vhl+/; 
vll/; Tg (phd3:: EGFP)i144 pair mating and treated them 
with CPT to examine the effect of p53 downregulation on 
the LOH formation in vhl locus. We counted the number 
of EGFP positive cells in the vhl+/; vll/ embryos that 
are induced by CPT treatment and compared with the 
number of EGFP positive cells in the p53 morpholino 
injected vhl+/; vll/ embryos. There was no significant 
difference in the number of EGFP positive cells between 
p53 morpholino injected and uninjected vll/ embryos, 
indicating the role of Hif in the promoting DNA repair 
is through p53 independent mechanism (Figure 9A9C, 
quantified in 9D).
brca2/ mutants are sensitive to X-ray 
treatment induced cell death and an elevated 
Hif level in the vhl/ mutants alleviates the cell 
death induced by mutation in brca2
As the precise relationship of Vll to DNA repair is still 
very poorly understood, we sought to look at the effect of Hif 
on well-established DNA repair gene mutations. Firstly, we 
created a brca2 mutant allele using the CRISPR/Cas9 system. 
The brca2 mutant allele for this experiment contained an 
83 bp insertion at the amino acid 445 (exon 10) position 
introducing premature stop. When embryos from brca2+/ 
pair-mating were treated with X-rays, we found that there 
was increased cell death in homozygous brca2/ embryos, 
especially in the central nervous system (CNS) as previously 
reported [39]. In contrast, the least affected embryos were all 
either brca2+/ or brca2+/+ (Figure 10A). We confirmed the 
increased apoptosis in the brca2/ embryos in comparison 
to their siblings by Acridine Orange staining (Figure 10B).
We then proceeded to check whether elevated Hif 
activation seen in the vhl/; vll/ mutants can also 
suppress the increased sensitivity of brca2/ embryos to 
genotoxic stress. We generated brca2+/; vhl+/; vll/ 
mutants. The embryos from brca2+/; vhl+/; vll/ in 
cross were treated with X-rays at 1dpf and examined for 
the cell death in the CNS 2 days post X-ray. This revealed 
that the increased apoptosis in the brca2/ mutant was 
suppressed by the presence of vhl/; vll/ and that in 
this background, brca2/ embryos were indistinguishable 
from their siblings, suggesting that the elevated Hif can 
strongly suppress the sensitivity of brca2/ embryos to 
X-ray induced apoptosis (Figure 10D).
Figure 6: p53 expression in the vhl/; vll/ double mutants is downregulated in comparison to that in their siblings. 
(A and B) Embryos from vhl+/; vll/SDLUPDWLQJZHUHFROOHFWHGDQGLUUDGLDWHGDWGSIZLWKȖUD\DWDGRVHRIJUD\T3&5ZDV
SHUIRUPHGKRXUVSRVWȖUD\WRTXDQWLI\WKHIXOOOHQJWKRISDQGVKRUWIRUPRIǻS7KLVUHYHDOHGWKDWWKHUHZDVDVLJQLILFDQW
decrease in both forms of p53 expression in the vhl/; vll/ embryos in comparison to their siblings. ****p < 0.0001, two way ANOVA 
test. The statistical analysis was performed with ddCt values. (C) We also treated embryos from vhl+/; vll/ incross with 10 nM CPT and 
both isoforms of p53 induction was examined in the vhl/; vll/ embryos and in their siblings by Western blot. After treatment, there was 
a clear reduction in both isoforms of p53 expression in the vhl/; vll/ embryos in comparison to their siblings.
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We also treated brca2/ embryos and their siblings 
with CPT with or without Hif activator pre-treatment. 
There was a significant suppression in the CPT induced 
apoptosis in the brca2/ embryos when they were pre-
treated with Hif activator, although not to the same level 
as that in their siblings. We speculate that the elevation 
of Hif level by chemical Hif activator treatment is not 
as powerful as that induced by the loss of Vhl and Vll 
(Supplementary Figure 6).
In addition, we examined the effect of the loss of 
brca2 in the rate of loss of vhl alleles in the brca2/; Tg 
(phd::3EGFP)i144 embryos by X-ray treatment. When we 
exposed the embryos from brca2+/; Tg (phd::3EGFP)i144 
pair mating to a high dose of X-ray, there were a few cells 
expressing a high level of EGFP in brca2/ embryos, 
indicating that these cells had lost both vhl wild type 
alleles, in contrast to their siblings in which there were 
hardly any EGFP positive cells. When these embryos 
were pre-incubated with Hif activator before the X-ray 
treatment, the number of EGFP positive cells in the brca2
/ embryos was profoundly reduced, proving the role of 
Hif in the protection of brca2/ embryos from the X-ray 
induced DNA damage (Figure 10C).
Hif activation abrogates the sensitivity to CPT 
induced cell death in ATM inhibitor treated 
embryos
Another fundamental regulator of the DNA damage 
response is ATM (ATM serine/threonine kinase), and ATM 
deficient cells are highly sensitive to genotoxic stresses [40]. 
Patients with mutations in ATM develop A-T syndrome 
that are characterised by progressive neurodegeneration, 
increased risk of cancer development, radiosensitivity 
and immune system impairment. We wondered whether 
Hif activator can mitigate the effect of the loss of ATM 
through its role in the anti-apoptosis and DNA repair. We 
treated wild type embryos with 10 nM CPT with or without 
pre-incubation with 10 PM ATM inhibitor (ATMi). As 
expected, ATMi treated embryos were highly sensitised 
to CPT treatment with increased apoptosis in the brain in 
comparison to ATMi untreated embryos. However, when 
the embryos were treated with Hif activator in combination 
with ATMi before CPT treatment, Hif activator treated 
embryos were well protected from CPT induced cell death 
(Figure 11A11C; quantified in 11G). We also observed the 
protection of ATMi treated embryos from X-ray induced 
LOH by Hif activator treatment. ATMi treated embryos 
were highly sensitised to X-ray treatment with increased 
LOH at the vhl locus in comparison to ATMi untreated 
embryos. On the contrary, when the embryos were treated 
with both Hif activator and ATMi, the increased LOH at 
the vhl locus was dramatically reduced (Figure 11D11F; 
quantified in 11H).
HIF activator treatment does not protect human 
MRC5 cells from X-ray treatment
We were very surprised by the strength of the 
protective effect that Hif conferred in zebrafish embryos 
Figure 7: p53 knock down by p53 morpholino injection protects embryos from CPT induced apoptosis. (A) Embryos 
collected from vhl+/; vll/ pair mating were treated with 10 nM CPT. This resulted in severe cell death in the CPT treated embryos with 
the exception of GFP positive vhl/; vll/ double mutants. (B) On the contrary, when p53 morpholino was injected into the embryos prior 
to 10 nM CPT treatment, all the embryos were protected from CPT induced apoptosis. (C) The similar protection was also observed in the 
embryos treated with Hif activator prior to CPT treatment. Only GFP negative embryos were imaged and quantified for this experiment. 
(D) The image quantification of levels of apoptosis using gray scale in ImageJ, low gray scale values denote high levels of apoptosis. ****p 
< 0.0001, one-way ANOVA. Scale bar: 0.5 mm.
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and we were eager to see if it is conserved in cultured 
human cells. As cancer cells may have defects in p53 or 
other relevant pathways, we initially chose MRC5 that 
is the most common human diploid fibroblasts cell line 
derived from normal lung tissue of a 14 weeks old male 
fetus. We took MRC5 cells with or without HIF activator 
(FG4592) at 15 uM concentration and the cells were 
incubated for 3 hours at 37°C followed by X-ray treatment 
at 5 gray. The cells were fixed 4 hours and 24 hours post 
LUUDGLDWLRQKSLDQGVWDLQHGZLWKȖ+$;WRH[DPLQHWKH
DNA damage foci. Surprisingly, we observed that there 
ZDVQRVWDWLVWLFDOGLIIHUHQFHLQȖ+$;IRUPDWLRQEHWZHHQ
the HIF activator treated group and non-treated group at 
both time points (Figure 12A). In our second experiment, 
we decided to lower the X-ray dose to 2 gray since we 
FRXOGQRWREVHUYHWKHUHVROXWLRQRIȖ+$;DWKSLIURP
the first experiment and tested an alternative cell line, 
human osteosarcoma U2OS. U2OS cells were treated with 
HIF activator (JNJ-42041935) at 100 uM concentration 
and incubated cells for 3 hour before the X-ray treatment 
at 2 gray. The cells were fixed 30 minutes post irradiation 
PSLDQGKSL WRH[DPLQHȖ+$;IRUPDWLRQ:KHQ
ZH FRXQWHG WKHQXPEHURI Ȗ+$; IRFLZH VWLOO FRXOG
not observe the genoprotective effect of HIF activator 
treatment at both time points (Figure 12B).
Hif activator treatment does not promote colony 
formation in the MRC5 cells
As an alternative readout for Hif mediated protection 
to DNA damaging treatment in cell culture, we performed 
a clonogenic survival assay. The MRC5 cells (4000 cells) 
were seeded a day before the drug treatment. The cells 
were then treated with HIF activators with or without ATM 
inhibitor. 3 hours later, CPT was added either at 10 nM or 
25 nM concentration. The drugs were washed off after 1 
hour incubation. The cells were then left to form colonies 
in the 37°C CO
2
 incubator. Seven days later, the colony 
formation was examined. There was decreased number 
of colonies in the CPT/ATM inhibitor treated cells in 
comparison to untreated control cells. Unlike in zebrafish, 
however, in the cell culture studies, we could not find any 
increase in the survival rates in the HIF activator treated 
cells in comparison to the non-treated cells (Figure 13).
Figure 8: Hif activator treatment protects embryos from X-ray induced DNA damage. (AD) We investigated the effect 
of Hif activation on the increased LOH in vhl locus in vll/ mutant embryos. When embryos were treated with Hif activator prior to 
X-ray treatment, the increased LOH in the vhl locus in vll/ embryos was significantly reduced (B) in comparison to vll/ embryos that 
were exposed to X-ray without Hif activator treatment (D). (E) The effect of Hif activator on the LOH suppression in the vhl locus was 
quantified. ****p < 0.0001, unpaired t-test. Hif activator treated vll/ embryos also looked more healthier (A) than untreated embryos (C). 
(F) The size of eyes was measured as a surrogate for general health, and quantified in the Hif activator treated and untreated embryos. ****p 
< 0.0001, unpaired t-test. Scale bar: 1 mm.
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DISCUSSION
ccRCC is one of the most difficult cancers to 
treat because of its resistance to chemotherapies and 
radiotherapies. Although a few targeted therapies have 
improved the survival rates of ccRCC patients to a 
certain extent, advanced ccRCC still remains incurable. 
In addition, unlike some other tumor suppressor proteins, 
pVHL is a highly multifunctional protein that makes 
it difficult to design target therapies against. Evidently 
upregulated HIF in ccRCC provides survival advantages 
to cancer cells. The activation of HIF, however, although 
necessary for the ccRCC progression, is not sufficient to 
initiate tumor development [4143].
According to the mutator phenotype theory in 
cancer, the rate of random mutations cannot explain 
the frequency of mutations in cancer, and the mutations 
in the genes that are essential for the maintenance of 
genomic stability, including genes that are involved 
in DNA repair, have been speculated to increase the 
mutation rates and drive cancer development [44, 45]. 
In line with this theory, Metcalfe et al. demonstrated 
that human pVHL is required for the DSBR in the 
ccRCC cell lines, leading us to speculate that the loss 
of DNA repair function of VHL might account for the 
initiation of ccRCC in the VHL patients [7]. We set 
out to corroborate these data using a whole organismal 
vertebrate model, zebrafish, to overcome the limitation 
of the already transformed cancer cell lines for the 
functional studies for VHL.
We found that in zebrafish, among two VHL 
orthologous genes, the role of VHL in HIF regulation is 
mainly performed by Vhl, whereas the role of Vll in Hif 
regulation is very modest. We found that, consistent with 
the studies in the ccRCC cell lines, vll mutant embryos were 
more susceptible to genotoxic stress and induced increased 
LOH in our assay with Tg (phd3:: EGFP)i144 reporter line, 
indicating the role of VHL in DNA repair is conserved in Vll 
in zebrafish. However, when we performed deep sequencing 
around the target sites of CRISPRs against AR and Vhl, the 
rate of mutation frequencies generated in vll mutants was 
not significantly different from vll wild type embryos. The 
precise reasons for this remain unclear, perhaps the defects 
that are observable by the LOH assay may consist of more 
significant changes to the vhl containing chromosome, e. 
g. the loss of a chromosome arm, as is thought to occur 
in VHL patients [33]. As our next gene sequencing assay 
is based on PCR amplification, such deletion events go 
undetected. In order to get a better understanding of the 
genoprotective effect of HIF, it would be highly interesting 
to look at such chromosomal events, however this would 
require genome analysis in individual embryonic cells. Such 
single-cell ploidy analysis is now becoming feasible [46].
We hypothesized that Vhl might have a more 
dominant role in the DNA repair than its paralogous gene 
Vll, considering its higher homology with human VHL. 
Figure 9: p53 knock down by p53 morpholino does not affect the number of LOH at the vhl locus induced by CPT. (A) 
The embryos collected from vhl+/; vll/ pair mating were treated with 10 nM CPT. There was GFP positive cells throughout the CPT 
treated embryos indicating the LOH in these cells. (B) A similar number of GFP positive cells were observed in the p53 morpholino injected 
embryos suggesting that the CPT induced LOH formation in these embryos is independent of p53 level. (C) On the contrary, the treatment 
of Hif activator prior to CPT treatment abolished the LOH formation in the embryos, signifying the genoprotective role of Hif against CPT 
treatment. (D) The number of EGFP positive cells were quantified using ImageJ (n = 10 per treatment). nsp > 0.05, ****p < 0.0001, one-way 
ANOVA. Scale bar: 0.5 mm.
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Unfortunately, we could not use Tg (phd3:: EGFP)i144 
LOH reporter assay to study the LOH in the vhl mutants, 
since all the cells in the vhl mutants already express a 
high level of EGFP and there is no wild type vhl allele 
remaining that can be used as reporter. We reasoned, 
however, that vhl/; vll/ double mutants will have an 
increased sensitivity to genotoxic stress, if not only vll but 
also vhl is involved in the DNA repair pathway. But in 
marked contrast to our expectation, we found that vhl/; 
vll/ double mutant embryos were highly protected from 
the genotoxic stress with much reduced apoptosis, when 
the embryos were treated with X-ray and CPT.
Considering the prominent upregulation of Hif in 
the vhl/; vll/ double mutants, we then tested whether 
the elevated Hif in double mutants is responsible for the 
protection of embryos from the genotoxic stress induced 
cell death. When we treated embryos with pharmacological 
Hif activator prior to X-ray and CPT treatment, Hif 
activation resulted in the protection of embryos from 
apoptosis induced by such genotoxic stressors, even in 
the presence of intact vhl and vll. Injection of dominantly 
active form of Hif into the newly fertilized embryos 
also resulted in the protection of embryos from the CPT 
treatment in the same way as pharmacological activation 
of Hif results, confirming the role of Hif in the providing 
embryos with protection against genotoxic stress.
In addition, when pharmacologically activated, 
Hif suppressed the increased LOH in the vll mutants. 
We speculate that this may happen by activating as yet 
unidentified DNA repair pathways. As a result, in the 
vhl/; vll/ double mutants in which there is a maximal 
level of increased Hif signaling, the DNA repair defect 
due to the lack of vll was suppressed by the elevated Hif 
activation and the embryos were well protected from 
Figure 10: The elevated Hif level in the vhl/ mutants alleviates cell deaths induced by the mutation in brca2. (A) 
brca2/ embryos were more sensitive to X-ray treatment in comparison to their siblings demonstrating the increased cell death in CNS. 
****p < 0.0001, unpaired t-test. (B) The Acridine Orange staining confirmed the increased apoptosis in the brca2/ embryos. ***p < 0.001, 
unpaired t-test. (C) X-ray treatment induced a few EGFP positive cells in the brca2/ embryos, indicating the loss of both vhl alleles in 
these embryos. On the other hand the EGFP positive cells were hardly observed in their siblings. The Hif activator treatment suppressed the 
appearance of EGFP positive vhl mutant cells in the brca2/ embryos. ***p < 0.001, one way AVOVA. (D) brca2/ embryos were more 
sensitive to X-ray treatment in comparison to their siblings. However, when the vhl /;vll / mutations are introduced in the brca2/ 
embryos, increased apoptosis in the CNS of brca2/ embryos was suppressed and the brca2/ embryos were indistinguishable from their 
siblings. ***p < 0.001, ****p < 0.0001, nsp > 0.05, one way ANOVA. Scale bars: 0.5 mm.
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DNA damage and apoptosis. On the contrary, the weak 
upregulation of Hif in the vll single mutants was not 
sufficient to suppress the DNA repair defect caused by 
the lack of Vll function in DNA repair, manifesting the 
increased LOH in the vhl locus in response to ionizing 
irradiation.
Our data suggest that zebrafish VHL homologues 
play two opposing roles. On the one hand, they suppress 
DNA repair by suppressing Hif; on the other, vll promotes 
DNA repair. Therefore, we speculate that the balance of 
these two opposing roles of VHL might be associated with 
cancer initiation. HIF activation might initially be able to 
Figure 11: Hif activation abolishes the sensitivity to CPT induced cell death in ATM inhibitor treated embryos. (A) The 
wild type embryos were treated with 10 nM CPT to induce cell death in the CNS. (B) When the embryos were treated with ATMi before 
CPT treatment, the embryos were highly sensitised to CPT treatment and induced severe cell death in the CNS. (C) When the embryos were 
treated with Hif activator in combination with ATMi prior to CPT treatment, the embryos were well protected from CPT/ATMi induced cell 
death in CNS. The quantification of the data is shown in (G) ****p < 0.0001, one way ANOVA. (D) The vhl+/; vll/; Tg (phd3:: EGFP)i144 
embryos were treated with X-ray to induce LOH at the vhl locus. (E) When the vhl+/; vll/; Tg (phd3:: EGFP)i144 embryos were treated 
with ATMi before the X-ray treatment, there was a dramatic increase in the LOH in the vhl locus in the ATMi treated embryos. (F) When 
the embryos were treated with Hif activator in combination with ATMi before the X-ray treatment, there was a remarkable reduction in 
the LOH in the vhl locus. The quantification of the data is shown in (H) *p < 0.05, ****p < 0.0001, one way ANOVA. Scale bars: 0.5 mm.
Figure 12: HIF activation does not protect mammalian cells from X-ray induced DNA damage. (A) We treated MRC5 cells 
with HIF activator FG 4592 for 3 hours prior to X-ray treatment at 5 gray. The cells were fixed at 4 hpi and 24 hpi with 4% PFA and stained 
ZLWKȖ+$;7KLVUHYHDOHGWKDWWKHUHZDVQRVLJQLILFDQWGLIIHUHQFHLQWKHȖ+$;IRUPDWLRQEHWZHHQ+,)DFWLYDWRUWUHDWHGFHOOVDQGQRQ
treated cells. nsp > 0.05, one way ANOVA. (B) The cells were treated with HIF activator JNJ-42041935 for 3 hours prior to X-ray treatment 
DWJUD\7KHFHOOVZHUHIL[HGDWPSLDQGKSLDQGVWDLQHGZLWKȖ+$;$WERWKWLPHSRLQWVZHFRXOGQRWREVHUYHWKHUHGXFWLRQLQ
Ȗ+$;IRUPDWLRQLQWKH+,)DFWLYDWRUWUHDWHGJURXSLQFRPSDULVRQWRXQWUHDWHGJURXS$WPSLWKHUHZDVHYHQDQLQFUHDVHLQWKHQXPEHU
RIȖ+$;IRFLLQWKH+,)DFWLYDWRUWUHDWHGJURXSLQRSSRVLWLRQWRRXUH[SHFWDWLRQnsp > 0.05, *p < 0.05, one way ANOVA.
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mask effects of the loss of VHL on genomic stability, 
however when the malignant cells finally form, they will 
be protected by the strong antiapoptotic function of HIF. 
Our data is consistent with resistance to the chemo and 
radio therapies seen in later stage of ccRCC in human 
through HIFs role in DNA repair and suppression of 
apoptosis. We propose zebrafish vhl/; vll/ mutants as 
an excellent platform for the screening for drugs that can 
interfere with the protection that is conferred by Hif, and 
therefore overcome resistance.
We discovered that the level of p53 was 
downregulated in vhl/; vll/ double mutants in 
response to the ionizing irradiation in comparison to their 
siblings. In addition, when we injected embryos with p53 
morpholino, the injected embryos were all protected from 
CPT induced apoptosis even in the presence of intact vhl, 
suggesting that the decreased level of p53 is responsible 
for the protection of embryos from apoptosis in the vhl 
mutants, at least partially. This is consistent with in vitro 
studies in which the role of pVHL in the p53 activation 
has been demonstrated [37]. However, we propose that the 
downregulated p53 level in the zebrafish vhl mutants is 
due to the elevated Hif, rather than by the Hif independent 
role of Vhl in regulation of p53. Importantly we found 
that the downregulation of p53 did not affect the increased 
LOH in the vll mutants, signifying the fact that the role of 
Hif is not simply in regulating the level of p53, but Hif 
has a genuine role in the DNA repair. The downregulation 
of p53 could be the consequence of reduction in DNA 
damage due to the function of Hif in DNA repair.
Most interestingly, Hif activation also suppressed 
the increased apoptosis and DNA damage induced by 
X-ray and CPT treatment in the brca2 mutant and in the 
embryos with deficient ATM function. Both BRCA2 and 
ATM play important roles in the DNA repair pathways 
in human and their mutations increase the risk of cancer 
development. In addition, one of the distinctive features 
of A-T syndrome caused by the deficient ATM function 
is the defective movement and coordination due to 
neurodegeneration in cerebellum [47]. Similarly, the 
mutations in genes that encode proteins in the DNA repair 
machineries often lead to congenital neurodegenerative 
disorders in human, highlighting the importance of 
maintaining the genomic stability in the nervous system. 
For example, mutations in MRE11, TDP1 and aprataxin 
(APTX) result in neurodegenerative disorders such as 
A-T like disease (ATLD) [48], spinocerebellar ataxia 
with axonal neuropathy (SCAN1) [49], and ataxia-
oculomotor apraxia-1 [50, 51] respectively. The efficacy 
of Hif activators for the suppression of DNA damage and 
apoptosis in brca2 mutants and ATM inhibitor treated 
embryos in our study suggests that HIF activators might 
Figure 13: Hif activator treatment does not affect the survival of MRC5 cells. 4000 MRC5 cells were seeded in 6 well plates 
and left to grow overnight. The next day, the cells were treated with HIF activator (FG4592 or JNJ-42041935) and ATMi for 3 hours. CPT 
was added at either 10 nM or 25 nM concentration for 1 hour and the drugs were washed off. The colony formation was examined 7 days 
after the drug treatment. CPT/ATMi treatment decreased the survival rates but we could not find any effect of HIF activator on the survival 
of MRC5 cells. nsp > 0.05, unpaired t-test.
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provide a possible intervention to slow the progression of 
such congenital neurodegenerative disorders.
Unfortunately, we could not reproduce the data we 
generated in the zebrafish in MRC5 and U2OS cells; HIF 
activation did not protect cells from X-ray induced DNA 
damage in these cell lines. HIF activator treatment did not 
affect the survival rates of cells after CPT treatment in 
the MRC5 cells either. We cannot currently explain why 
this is the case. We wanted to use the cell lines to gain 
mechanistic insight with regard to the particular DNA 
lesions and specific DDR proteins that are affected by 
HIF activation, taking advantage of abundant resources of 
antibodies which are available in the cell culture system. 
Nevertheless, our in vivo data are very clear, and it is 
perhaps an illustration of the importance of using in vivo 
systems to complement cell culture work. When cells 
are taken in culture and expanded, there is a strong and 
continuous selection for cells that can resist apoptosis and 
divide rapidly, thus cultured cells may have lost relevant 
characteristics (e. g. appropriate p53 activity) that are 
present in vivo. Perhaps the use of primary cells may 
overcome these issues. Currently, the limitation of our 
study is the lack of mechanistic understanding. We are 
left to raise questions: Against what specific DNA lesions 
does Hif activation protect? Are there any other targets 
of Hif than p53 that provide survival advantages to the 
cells lacking the functional Vhl? Given time, we could 
use mutants and treatments that lead to defects in various 
DNA repair pathways, and study how Hif activation can 
modulate the response such genotoxic stressors.
In summary, we discovered that HIF regulation and 
DNA repair role of human VHL are conserved in zebrafish 
vhl and vll. The activated Hif in the vhl; vll mutants 
strongly suppresses DNA damage and apoptosis induced 
by genotoxic stress. We speculate this could parallel 
resistance to chemo- and radio therapies in ccRCC, 
and propose zebrafish vhl/; vll/ double mutants as 
a powerful model for the development of therapeutic 
reagents to overcome the resistance of ccRCC to chemo- 
and radio therapies. We found Hif activation suppresses 
the DNA damage in the brca2 and vll mutants and ATM 
deficient embryos and also prevents apoptosis. Currently 
at least one HIF activator is in the phase III clinical trials 
for the treatment of anemia [52, 53]. Our results suggest 
that clinical benefits of HIF activation could expand 
beyond treatment of anemia, to that of disorders linked 
with DNA repair deficiency, like Ataxia Telangiectasia.
MATERIALS AND METHODS
Zebrafish husbandry
All the zebrafish strains used in this paper are 
maintained on 10/14 hours dark/light cycle at 28°C 
according to the UK home office regulation at the 
University of Sheffield.
Mutagenesis
We generated vll mutants by zinc finger nucleases 
(ZFNs) purchased from Sigma-Sangamo Biosciences. 
A pair of ZFNs designed to bind the following 
sequences (in capitals) showed good activity when 
RNA encoding these was injected into embryos, and 
the efficiency of them was assayed by the loss of NcoI 
site (underlined) that covers the start ATG (bold) of vll. 
caCAGCTCATCCATGGtgcaGAGCATCTGATGGAGct 
brca2 mutants were induced by CRISPR/Cas9 system. 
The sequence of gRNA targeting brca2 is as follow. 
ƍ7**&77**$7$7*$&$&$&&ƍ7KHbrca2 mutant 
allele, brca2sh515, contains an 83bp insertion at the amino 
acid 445 (exon 10) position introducing premature stop.
Cell culture
MRC5 and U2OS cells were grown in Minimum 
Essential Media (MEM; Sigma-Aldrich) supplemented 
with 10% fetal bovine serum (Sigma-Aldrich), 2% 
L-glutamine (Sigma-Aldrich).
Ionizing irradiation treatment in zebrafish
Zebrafish embryos were irradiated at 20 Gray at 
GSI RU  GSI ZLWK ȖUD\ XVLQJ WKH LUUDGLDWRU &,6 ELR
international) at the Royal Hallamshire Hospital animal 
facility or with X-ray using the irradiator (Faxitron X-ray 
Corporation) at the Biomedical Science Department at the 
University of Sheffield.
Injections into zebrafish embryos
CRISPR against vhl and AR was injected into 
the newly fertilized 1-cells stage embryos using 
microinjector (Pneumatic PicoPump WPI) at 100 
uM concentration at 1 nl volume. Target sequences 
were CCGCACGAGCAGTGGTACCC (ar) and 
CAGCCGTACGTGAACATTCC (vhl). Image analysis 
to determine LOH levels in vhl+/; Tg (phd3:: EGFP)
i144 vs vhl+/; vll/; Tg (phd3:: EGFP)i144 embryos was 
performed as illustrated in Supplementary Figure 7.
Deep sequencing
The embryos from vhl+/ pair mating and vhl+/; 
vll/ pair mating were collected and the 15 embryos 
per each genotype were selected. After genomic DNAs 
were extracted from each group, the deep sequencing 
was performed with the primers shown below with three 
biological replicates.
Forward primers for AR: 
TCGTCGGCAGCGTCAGATGTGTATAAGAGAC 
AGCCT CCA AAG CAA AGG ACA CC (inner primer), 
ATGCCCCGTGATCTGAATGA (outer primer), 
Reverse primers for AR: GTCTCGTGGGCTCGGA 
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GATGTGTATAAGAGACAGAAA TCAGTTGTGGC 
GCAGAG (inner primer), ACCCTGTGCACGGTGTATTA 
(outer primer), Forward primers for vhl: 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 
TGAAGCTTTAGTCTAACTCGGTG (inner primer), 
CACGAACCCACAAAAGTTGTTAT (outer primer), 
Reverse primers for vhl: GTCTCGTGGGCTCG 
GAGATGTGTATAAGAGACAG AATTCAGCATAATTT 
CACGAACC (inner primer), CTTCACCGACTCT 
CACAAGATTA (outer primer). Analysis of mutations 
frequencies and sizes was performed using BATCH-GE [54, 
55].
Immunostaining in zebrafish
Embryos were fixed at 20°C with methanol: 
acetone (50%:50%). Embryos were then permeabilised 
with 1% triton for 1 hour. The embryos were subsequently 
incubated in the blocking solution (2% Roche block, 5% 
FDOIVHUXP'062Ȗ+$;DQWLERG\*7;
GeneTex,) was treated at 1:1000 dilution and incubated 
overnight. Secondary antibody (Alexa Flore 488 or Alexa 
Flore 546, Molecular Probe) was treated at 1:1000 and the 
embryos were incubated for 2 hours at room temperature. 
After the washing, the embryos were visualized using a 
confocal microscope.
Chemical treatment
ATM inhibitor (KU-55933, Sigma-Aldrich) was 
treated both in zebrafish and cell cultures at 10 uM 
concentration. HIF activators (FG 4592, Stratech or JNJ-
42041935, Johnson and Johnson) were treated at 1550 
uM and 100 uM respectively in zebrafish and in cell 
cultures. CPT ((S)-(+)-Camptothecin, Sigma Aldrich) was 
treated at 1025 nM concentration in zebrafish and in cell 
cultures as indicated in the text.
TUNEL staining
3 hours after the irradiation with X-ray, the 
embryos were fixed with 4% PFA overnight at 4°C. 
The embryos were washed 3 times for 5 minutes with 
3%6DQGSHUPHDELOLVHGZLWKȝJPOSURWHLQDVH.IRU
20 minutes. The fixed embryos were then washed and 
stained using the ApopTag Red in situ apoptosis detection 
kit (Chemicon).
q-RCR for full length and short form of p53
The embryos from vhl+/ pair mating and vhl+/; 
vll/ pair mating were collected and raised to 2dpf. Then 
WKHHPEU\RVZHUHLUUDGLDWHGZLWKȖUD\DWJUD\GRVH
The embryos were pools according to their genotype and 
Total RNA was extracted. The specific TaqMan probes for 
full length and short form of p53 were designed and qPCR 
was performed after the first strand cDNA synthesis.
Western analysis
40 embryos were collected for each sample. The 
yolk was removed from the embryos with 1 ml of ice-
cold PBS by pipetting up and down with yellow tip several 
times. The 50 ul of lysis buffer (200 mM Hepes, 40 mM 
NaCl, 2 mM MgCl2, 0.5% Triton X-100, 1 × protease 
inhibitor (Roche, 4693159001), 1 × phosphatase inhibitor 
(Roche, 4906837001), 25 U/mL BaseMuncher (Expedeon, 
BM0025)) was added to each sample, which was followed 
by 30 minute incubation on ice. Then the samples were 
centrifuged for 15 minutes at 4°C, and the lysate was 
transferred into fresh Eppendorf tubes. The amount of 
protein was quantified in each sample by Bradford assay 
in Jenway visible spectrophotometer (Genova, 6320D). 
40 ug of protein for each sample was mixed with 5xPLB 
(protein loading buffer) and H
2
O to make up the final 
volume of 25 ul. The samples were denatured at 95°C for 5 
minutes and loaded on the 415% precast polyacrylamide 
gel (Bio-rad 4561983). The gel was then transferred 
onto the nitrocellulose membrane (Bio-Rad, 170-4271) 
using the Trans-Blot Turbo® transfer system (Bio-Rad, 
17001915). The membrane was blocked in 5% milk/TBST 
(200 mM Tris, 140 mM NaCl, 0.1% Tween-20, pH 7.4) 
for 1 hour and incubated in p53 antibody [38] at 1:200 
dilution overnight at 4°C. Next day the membrane was 
washed for 5 minutes 3 times in TBST, and incubated 
in the secondary antibody (anti-mouse IgG (H+L) -HRP 
conjugate (Bio-Rad (170-6516)) at 1:4000 dilution for 1 
hour. After 5 minute wash 3 times, Luminol/enhancer and 
peroxide reagents (Bio-Rad, 1705060) were added onto 
the membrane at 1:1 ratio and the staining was visualised 
in the ChemiDoc MP imaging system (Bio-Rad, 1708280).
Acridine orange staining
Acridine Orange (A6014, Sigma Aldrich) was 
prepared at 1 mg/ml (×100, stock solution) in miliQ water, 
and stored at 20°C. The embryos were incubated in ×1 
Acridine Orange for 30 minutes in E3 fish medium. The 
embryos were washed three times each for 10 minutes.
Immunostaining in the MRC5 and U2OS cells
70,000 of either MRC5 cells or U2OS cells were 
seeded onto the cover slips in the 24 well plates, and the 
cells were grown overnight at 37°C. Then the cells were 
treated with HIF activator for 3 hours followed by x-ray 
treatment with a dose of either 5 or 2 gray dose. The 
irradiated cells were fixed with 4% PFA for 10 minutes 
after 30 minutes, 4 hours and 24 hours irradiation. The 
fixed cells were permeabilized with 0.2% tween and 
blocked for 1 hour with 3% BSA. The primary antibody 
gH2AX (mouse JWB301-Milipore) was added at 1:500 
dilution and the cells were incubated in the primary 
antibody overnight at 4°C. Next day, anti-mouse Alexa 
Flour 594 (Invitrogen A11005) was added and the cells 
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were incubated in the secondary antibody for one hour. 
The cells were counter stained with DAPI before mounting 
with mounting solution.
Clonogenic studies
4000 cells per well were plated into the 10 cm 
plates. After leaving the cells to grow overnight at 
37°C, cells were treated with chemicals, either ATMi at 
10 uM concentration alone or ATMi and HIF activators 
JNJ-42041935 at 100 uM or FG 4592 at 50 uM and 
incubated at 37°C for 3 hours. Next CPT was added to 
the wells at 10 nM or 25 nM concentration, and cells 
were incubated 1 hour. The drugs were poured off and 
the fresh media were added to the plates. The cells were 
then returned to 37°C incubator for another 7 days for 
the colony formation. When the colonies are formed, 
the media were poured off and cells were fixed with 
80% ethanol. After the cells were left to dry, they were 
stained with 1% methylene blue for 1 hour. Finally 
the plates were rinsed with water and colonies were 
counted.
Statistical analysis
The data were analysed using the GraphPad 
program. All data were presented with the mean value of 
s. e. m. Statistical difference was analysed by the students 
t-test for two groups of data, one-way ANOVA for more 
than two groups. Two-way ANOVA test was performed 
to determine the effect of X-rays and mutations on the 
H[SUHVVLRQOHYHOVRISDQGǻS7KHVLJQLILFDQFH
of Hif activation on the survival of zebrafish embryos 
was tested by chi-square test. p < 0.05 was considered 
statistically significant.
Imaging
The embryos were visualized using Leica dissecting 
microscope and the images were captured using Leica 
Application System v4.9.0 software. The confocal 
images were acquired using Olympus FV1000 available 
at the light microscope facility at the Biomedical Science 
Department at the University of Sheffield.
Abbreviations
VHL: Von Hippel Lindau; ccRCC: clear cell renal 
cell carcinoma; HIF: Hypoxia Inducible Factor; PHD: 
Prolyl Hydroxylase; HRE: HIF responsive element; DSB: 
double strand break; HR: homologous recombination; 
A-T: Ataxia -Telangiectasia; MMR: mismatch repair; 
LOH: loss of heterozygosity; TUNEL: terminal 
deoxynucleotidyl transferase dUTP nick end labelling; 
CPT: Camptothecin; CNS: central nervous system; ATM: 
ATM serine/threonine kinase; ATMi: ATM inhibitor; mpi: 
minutes post irradiation; APTX: aprataxin; ATLD: A-T 
like disease; SCAN1: spinocerebellar ataxia with axonal 
neuropathy; ZFN: zinc finger nucleases.
Author contributions
Kim HR, wrote the paper, designed and executed 
experiments. Santhakumar K, wrote the paper, designed 
and executed experiments. Markham E, executed 
experiments. Baldera D, executed experiments. Greenald 
D, carried out qPCR analysis. Bryant HE, designed 
experiments and commented on manuscript. El-
Khamisy SF, designed experiments and commented on 
manuscript. van Eeden FJ, designed experiments, executed 
experiments, wrote the manuscript.
ACKNOWLEDGMENTS
We thank Dan Harris and Dr Shih-Chieh Chiang for 
help with cell culture work. The Bateson Centre aquaria 
VWDIINLQGO\SURYLGHGFDUHIRU]HEUD¿VK:HDOVRZRXOG
OLNHWRWKDQN(OLVDEHWK.XJOHUIRUKHOSZLWKȖ+$;IRFL
counting script and Dr Phil Elks for providing us with the 
dominant active form of Hif constructs. We are also very 
grateful to professor Jinrong Peng for providing us with 
p53 antibody.
CONFLICTS OF INTEREST
None.
FUNDING
The work was supported by two BBSRC Grants: 
BB/R015457/1 and BB/M02332X/1.
REFERENCES
 1. Gossage L, Eisen T, Maher ER. VHL, the story of a tumour 
suppressor gene. Nat Rev Cancer. 2015; 15:5564. https://
doi.org/10.1038/nrc3844. [PubMed]
 2. Maher ER, Neumann HP, Richard S. von Hippel-Lindau 
disease: a clinical and scientific review. Eur J Hum Genet. 
2011; 19:617623. https://doi.org/10.1038/ejhg.2010.175. 
[PubMed]
 3. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert 
J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, 
Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, 
Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-
Lindau ubiquitylation complex by O2-regulated prolyl 
hydroxylation. Science. 2001; 292:468472. https://doi.
org/10.1126/science.1059796. [PubMed]
 4. Kaelin WG Jr. The VHL Tumor Suppressor Gene: Insights 
into Oxygen Sensing and Cancer. Trans Am Clin Climatol 
Assoc. 2017; 128:298307. [PubMed]
Oncotarget1128www.oncotarget.com
 5. Semenza GL. Hypoxia-inducible factors in physiology 
and medicine. Cell. 2012; 148:399408. https://doi.
org/10.1016/j.cell.2012.01.021. [PubMed]
 6. Li M, Kim WY. Two sides to every story: the HIF-
dependent and HIF-independent functions of pVHL. J 
Cell Mol Med. 2011; 15:187195. https://doi.org/10.1111/
j.1582-4934.2010.01238.x. [PubMed]
 7. Metcalf JL, Bradshaw PS, Komosa M, Greer SN, Stephen 
Meyn M, Ohh M. K63-ubiquitylation of VHL by SOCS1 
mediates DNA double-strand break repair. Oncogene. 
2014; 33:10551065. https://doi.org/10.1038/onc.2013.22. 
[PubMed]
 8. Scanlon SE, Hegan DC, Sulkowski PL, Glazer PM. 
Suppression of homology-dependent DNA double-strand 
break repair induces PARP inhibitor sensitivity in VHL-
deficient human renal cell carcinoma. Oncotarget. 2017; 
9:46474660. https://doi.org/10.18632/oncotarget.23470. 
[PubMed]
 9. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin 
WG Jr. von Hippel-Lindau protein mutants linked to type 
2C VHL disease preserve the ability to downregulate 
HIF. Hum Mol Genet. 2001; 10:10191027. https://doi.
org/10.1093/hmg/10.10.1019. [PubMed]
10. Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau 
KW, Gentle D, Shuib S, Serrano-Fernandez P, Lubinski 
J, Wiesener MS, Pugh CW, Latif F, Ratcliffe PJ, et al. 
Mutation analysis of hypoxia-inducible factors HIF1A 
and HIF2A in renal cell carcinoma. Anticancer Res. 2009; 
29:43374343. [PubMed]
11. Fu L, Minton DR, Zhang T, Nanus DM, Gudas LJ. Genome-
Wide Profiling of TRACK Kidneys Shows Similarity to 
the Human ccRCC Transcriptome. Mol Cancer Res. 2015; 
13:870878. https://doi.org/10.1158/1541-7786.MCR-14-
0423. [PubMed]
12. Gudas LJ, Fu L, Minton DR, Mongan NP, Nanus DM. The 
role of HIF1alpha in renal cell carcinoma tumorigenesis. J 
Mol Med (Berl). 2014; 92:825836. https://doi.org/10.1007/
s00109-014-1180-z. [PubMed]
13. Fu L, Wang G, Shevchuk MM, Nanus DM, Gudas LJ. 
Generation of a mouse model of Von Hippel-Lindau 
kidney disease leading to renal cancers by expression of 
a constitutively active mutant of HIF1alpha. Cancer Res. 
2011; 71:68486856. https://doi.org/10.1158/0008-5472.
CAN-11-1745. [PubMed]
14. Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, McMullin 
MF, Lee FS. A gain-of-function mutation in the HIF2A gene 
in familial erythrocytosis. N Engl J Med. 2008; 358:162168. 
https://doi.org/10.1056/NEJMoa073123. [PubMed]
15. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan 
Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell 
PH, Stockton DW, Semenza GL, et al. Disruption of oxygen 
homeostasis underlies congenital Chuvash polycythemia. 
Nat Genet. 2002; 32:614621. https://doi.org/10.1038/
ng1019. [PubMed]
16. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, 
Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194
1217. https://doi.org/10.1016/j.cell.2013.05.039. [PubMed]
17. Menck CF, Munford V. DNA repair diseases: What do they 
tell us about cancer and aging? Genet Mol Biol. 2014; 37:220
233. https://doi.org/10.1590/S1415-47572014000200008. 
[PubMed]
18. Spry M, Scott T, Pierce H, DOrazio JA. DNA repair 
pathways and hereditary cancer susceptibility syndromes. 
Front Biosci. 2007; 12:41914207. https://doi.
org/10.2741/2380. [PubMed]
19. Gatti R, Perlman S. Ataxia-Telangiectasia. In: Adam 
MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, 
Stephens K, Amemiya A, eds. GeneReviews((R)). Seattle, 
WA. 1993. https://doi.org/10.1007/978-3-642-78278-7. 
[PubMed]
20. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, 
Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. Specific 
killing of BRCA2-deficient tumours with inhibitors of 
poly(ADP-ribose) polymerase. Nature. 2005; 434:913917. 
https://doi.org/10.1038/nature03443. [PubMed]
21. Borrell B. How accurate are cancer cell lines? Nature. 2010; 
463:858. https://doi.org/10.1038/463858a. [PubMed]
22. Wilding JL, Bodmer WF. Cancer cell lines for drug discovery 
and development. Cancer Res. 2014; 74:23772384. https://
doi.org/10.1158/0008-5472.CAN-13-2971. [PubMed]
 ;LD<-LDQJ/=KRQJ77KHUROHRI+,)ĮLQFKHPR
radioresistant tumors. Onco Targets Ther. 2018; 11:3003
3011. https://doi.org/10.2147/OTT.S158206. [PubMed]
24. Calvo-Asensio I, Dillon ET, Lowndes NF, Ceredig R. The 
Transcription Factor Hif-1 Enhances the Radio-Resistance 
of Mouse MSCs. Front Physiol. 2018; 9:439. https://doi.
org/10.3389/fphys.2018.00439. [PubMed]
25. Lu C, El-Deiry WS. Targeting p53 for enhanced radio- and 
chemo-sensitivity. Apoptosis. 2009; 14:597606. https://
doi.org/10.1007/s10495-009-0330-1. [PubMed]
26. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot 
C, Muffato M, Collins JE, Humphray S, McLaren K, 
Matthews L, McLaren S, Sealy I, Caccamo M, et al. The 
zebrafish reference genome sequence and its relationship to 
the human genome. Nature. 2013; 496:498503. https://doi.
org/10.1038/nature12111. [PubMed]
27. van Rooijen E, Voest EE, Logister I, Korving J, Schwerte 
T, Schulte-Merker S, Giles RH, van Eeden FJ. Zebrafish 
mutants in the von Hippel-Lindau tumor suppressor display 
a hypoxic response and recapitulate key aspects of Chuvash 
polycythemia. Blood. 2009; 113:64496460. https://doi.
org/10.1182/blood-2008-07-167890. [PubMed]
28. van Rooijen E, Voest EE, Logister I, Bussmann J, Korving 
J, van Eeden FJ, Giles RH, Schulte-Merker S. von 
Hippel-Lindau tumor suppressor mutants faithfully model 
pathological hypoxia-driven angiogenesis and vascular 
retinopathies in zebrafish. Dis Model Mech. 2010; 3:343
353. https://doi.org/10.1242/dmm.004036. [PubMed]
Oncotarget1129www.oncotarget.com
29. Kim HR, Greenald D, Vettori A, Markham E, Santhakumar 
K, Argenton F, van Eeden F. Zebrafish as a model for von 
Hippel Lindau and hypoxia-inducible factor signaling. 
Methods Cell Biol. 2017; 138:497523. https://doi.
org/10.1016/bs.mcb.2016.07.001. [PubMed]
30. Santhakumar K, Judson EC, Elks PM, McKee S, Elworthy 
S, van Rooijen E, Walmsley SS, Renshaw SA, Cross SS, van 
Eeden FJ. A zebrafish model to study and therapeutically 
manipulate hypoxia signaling in tumorigenesis. Cancer Res. 
2012; 72:40174027. https://doi.org/10.1158/0008-5472.
CAN-11-3148. [PubMed]
31. Greenald D, Jeyakani J, Pelster B, Sealy I, Mathavan S, van 
Eeden FJ. Genome-wide mapping of Hif-1alpha binding 
sites in zebrafish. BMC Genomics. 2015; 16:923. https://
doi.org/10.1186/s12864-015-2169-x. [PubMed]
32. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, 
Landazuri MO, Del Peso L. Identification of a functional 
hypoxia-responsive element that regulates the expression of 
the egl nine homologue 3 (egln3/phd3) gene. Biochem J. 2005; 
390:189197. https://doi.org/10.1042/BJ20042121. [PubMed]
33. Pena-Llopis S, Christie A, Xie XJ, Brugarolas J. 
Cooperation and antagonism among cancer genes: the renal 
cancer paradigm. Cancer Res. 2013; 73:41734179. https://
doi.org/10.1158/0008-5472.CAN-13-0360. [PubMed]
34. Ryan AJ, Squires S, Strutt HL, Johnson RT. Camptothecin 
cytotoxicity in mammalian cells is associated with the 
induction of persistent double strand breaks in replicating 
DNA. Nucleic Acids Res. 1991; 19:32953300. https://doi.
org/10.1093/nar/19.12.3295. [PubMed]
35. Ashour ME, Atteya R, El-Khamisy SF. Topoisomerase-
mediated chromosomal break repair: an emerging player in 
many games. Nat Rev Cancer. 2015; 15:137151. https://
doi.org/10.1038/nrc3892. [PubMed]
36. Liao C, Beveridge R, Hudson JJR, Parker JD, Chiang 
SC, Ray S, Ashour ME, Sudbery I, Dickman MJ, El-
Khamisy SF. UCHL3 Regulates Topoisomerase-Induced 
Chromosomal Break Repair by Controlling TDP1 
Proteostasis. Cell Reports. 2018; 23:33523365. https://doi.
org/10.1016/j.celrep.2018.05.033. [PubMed]
37. Roe JS, Youn HD. The positive regulation of p53 by the 
tumor suppressor VHL. Cell Cycle. 2006; 5:20542056. 
https://doi.org/10.4161/cc.5.18.3247. [PubMed]
38. Gong L, Gong H, Pan X, Chang C, Ou Z, Ye S, Yin L, 
Yang L, Tao T, Zhang Z, Liu C, Lane DP, Peng J, et al. 
p53 isoform Delta113p53/Delta133p53 promotes DNA 
double-strand break repair to protect cell from death and 
senescence in response to DNA damage. Cell Res. 2015; 
25:351369. https://doi.org/10.1038/cr.2015.22. [PubMed]
39. Rodriguez-Mari A, Wilson C, Titus TA, Canestro C, 
BreMiller RA, Yan YL, Nanda I, Johnston A, Kanki JP, Gray 
EM, He X, Spitsbergen J, Schindler D, et al. Roles of brca2 
(fancd1) in oocyte nuclear architecture, gametogenesis, 
gonad tumors, and genome stability in zebrafish. PLoS 
Genet. 2011; 7:e1001357. https://doi.org/10.1371/journal.
pgen.1001357. [PubMed]
40. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the 
cellular response to genotoxic stress, and more. Nat Rev 
Mol Cell Biol. 2013; 14:197210. https://doi.org/10.1038/
nrm3546. [PubMed]
41. Smith K, Gunaratnam L, Morley M, Franovic A, Mekhail 
K, Lee S. Silencing of epidermal growth factor receptor 
suppresses hypoxia-inducible factor-2-driven VHL-/- renal 
cancer. Cancer Res. 2005; 65:52215230. https://doi.
org/10.1158/0008-5472.CAN-05-0169. [PubMed]
42. Hughes MD, Kapllani E, Alexander AE, Burk RD, 
Schoenfeld AR. HIF-2alpha downregulation in the 
absence of functional VHL is not sufficient for renal cell 
differentiation. Cancer Cell Int. 2007; 7:13. https://doi.
org/10.1186/1475-2867-7-13. [PubMed]
43. Nyhan MJ, OSullivan GC, McKenna SL. Role of the VHL 
(von Hippel-Lindau) gene in renal cancer: a multifunctional 
tumour suppressor. Biochem Soc Trans. 2008; 36:472478. 
https://doi.org/10.1042/BST0360472. [PubMed]
44. Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001; 
61:32303239. [PubMed]
45. Loeb LA, Bielas JH, Beckman RA. Cancers exhibit a 
mutator phenotype: clinical implications. Cancer Res. 2008; 
68:35513557. https://doi.org/10.1158/0008-5472.CAN-07-
5835. [PubMed]
46. van den Bos H, Bakker B, Taudt A, Guryev V, Colome-
Tatche M, Lansdorp PM, Foijer F, Spierings DCJ. 
Quantification of Aneuploidy in Mammalian Systems. 
Methods Mol Biol. 2019; 1896:159190. https://doi.
org/10.1007/978-1-4939-8931-7_15. [PubMed]
47. Biton S, Barzilai A, Shiloh Y. The neurological phenotype 
of ataxia-telangiectasia: solving a persistent puzzle. 
DNA Repair (Amst). 2008; 7:10281038. https://doi.
org/10.1016/j.dnarep.2008.03.006. [PubMed]
48. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan 
MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor 
AM. The DNA double-strand break repair gene hMRE11 
is mutated in individuals with an ataxia-telangiectasia-like 
disorder. Cell. 1999; 99:577587. https://doi.org/10.1016/
S0092-8674(00)81547-0. [PubMed]
49. Takashima H, Boerkoel CF, John J, Saifi GM, Salih MA, 
Armstrong D, Mao Y, Quiocho FA, Roa BB, Nakagawa M, 
Stockton DW, Lupski JR. Mutation of TDP1, encoding a 
topoisomerase I-dependent DNA damage repair enzyme, 
in spinocerebellar ataxia with axonal neuropathy. Nat 
Genet. 2002; 32:267272. https://doi.org/10.1038/ng987. 
[PubMed]
50. Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, 
Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, 
Takahashi T, Nagatomo H, et al. Early-onset ataxia with 
ocular motor apraxia and hypoalbuminemia is caused by 
mutations in a new HIT superfamily gene. Nat Genet. 2001; 
29:184188. https://doi.org/10.1038/ng1001-184. [PubMed]
51. Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, 
Gibson T, Mendonca P, Costa M, Barros J, Yanagisawa 
T, Watanabe M, Ikeda Y, Aoki M, et al. The gene mutated 
Oncotarget1130www.oncotarget.com
in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger 
protein aprataxin. Nat Genet. 2001; 29:189193. https://doi.
org/10.1038/ng1001-189. [PubMed]
52. Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar 
LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, 
Saikali KG, Franco M, Hemmerich S, et al. Roxadustat 
(FG-4592): Correction of Anemia in Incident Dialysis 
Patients. J Am Soc Nephrol. 2016; 27:12251233. https://
doi.org/10.1681/ASN.2015030241. [PubMed]
53. Provenzano R, Besarab A, Sun CH, Diamond SA, Durham 
JH, Cangiano JL, Aiello JR, Novak JE, Lee T, Leong R, 
Roberts BK, Saikali KG, Hemmerich S, et al. Oral Hypoxia-
Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat 
(FG-4592) for the Treatment of Anemia in Patients with 
CKD. Clin J Am Soc Nephrol. 2016; 11:982991. https://
doi.org/10.2215/CJN.06890615. [PubMed]
54. Boel A, Steyaert W, De Rocker N, Menten B, Callewaert 
B, De Paepe A, Coucke P, Willaert A. BATCH-GE: Batch 
analysis of Next-Generation Sequencing data for genome 
editing assessment. Sci Rep. 2016; 6:30330. https://doi.
org/10.1038/srep30330. [PubMed]
55. Boel A, Steyaert W, De Rocker N, Menten B, Callewaert 
B, De Paepe A, Coucke P, Willaert A. Publisher Correction: 
BATCH-GE: Batch analysis of Next-Generation 
Sequencing data for genome editing assessment. Sci 
Rep. 2018; 8:15845. https://doi.org/10.1038/s41598-018-
33869-y. [PubMed]
